Eliminating drugs from the body is a vital process that occurs through excretion or metabolism. Understanding the kinetics of drug elimination is crucial for drug development, dosage determination, and optimizing patient outcomes.
Drug clearance depends on the rate of drug elimination and its plasma concentration. Another important parameter is a drug's half-life, which is the time required for its concentration to decrease by half. In most cases, drug clearance follows first-order kinetics, where a constant fraction of the drug is eliminated per unit of time. This means that as the drug concentration increases, its elimination rate also increases. The relationship between drug concentration and time is exponential.
However, certain drugs, like phenytoin, aspirin, omeprazole, and fluoxetine, exhibit zero-order kinetics. When administered at high therapeutic doses, these drugs saturate the enzymes responsible for their metabolism. As a result, only a fixed amount of the drug is eliminated at a constant rate, regardless of its concentration. The plot of drug concentration versus time in zero-order kinetics is linear, indicating that increasing the drug concentration does not affect its elimination rate.
章から 6:
Now Playing
Pharmacokinetics: Drug Excretion and Clearance
395 閲覧数
Pharmacokinetics: Drug Excretion and Clearance
979 閲覧数
Pharmacokinetics: Drug Excretion and Clearance
100 閲覧数
Pharmacokinetics: Drug Excretion and Clearance
130 閲覧数
Pharmacokinetics: Drug Excretion and Clearance
88 閲覧数
Pharmacokinetics: Drug Excretion and Clearance
114 閲覧数
Pharmacokinetics: Drug Excretion and Clearance
132 閲覧数
Pharmacokinetics: Drug Excretion and Clearance
954 閲覧数
Pharmacokinetics: Drug Excretion and Clearance
79 閲覧数
Pharmacokinetics: Drug Excretion and Clearance
66 閲覧数
Pharmacokinetics: Drug Excretion and Clearance
34 閲覧数
Pharmacokinetics: Drug Excretion and Clearance
46 閲覧数
Pharmacokinetics: Drug Excretion and Clearance
45 閲覧数
Pharmacokinetics: Drug Excretion and Clearance
47 閲覧数
Pharmacokinetics: Drug Excretion and Clearance
37 閲覧数
See More
Copyright © 2023 MyJoVE Corporation. All rights reserved